These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

477 related items for PubMed ID: 28085519

  • 1. Association of retinal vein occlusion, homocysteine, and the thrombophilic mutations in a Turkish population: A case-control study.
    Koylu MT, Kucukevcilioglu M, Erdurman FC, Durukan AH, Sobacı G, Torun D, Tunca Y, Ayyildiz O.
    Ophthalmic Genet; 2017; 38(4):352-356. PubMed ID: 28085519
    [Abstract] [Full Text] [Related]

  • 2. Thrombophilic mutations as risk factor for retinal vein occlusion: a case-control study.
    Russo PD, Damante G, Pasca S, Turello M, Barillari G.
    Clin Appl Thromb Hemost; 2015 May; 21(4):373-7. PubMed ID: 24569626
    [Abstract] [Full Text] [Related]

  • 3. MTHFR C677T mutation, factor II G20210A mutation and factor V Leiden as risks factor for youth retinal vein occlusion.
    Cruciani F, Moramarco A, Curto T, Labate A, Recupero V, Conti L, Gandolfo GM, Balacco Gabrieli C.
    Clin Ter; 2003 May; 154(5):299-303. PubMed ID: 14994919
    [Abstract] [Full Text] [Related]

  • 4. Factor V G1691A, prothrombin G20210A, and methylenetetrahydrofolate reductase [MTHFR] C677T gene polymorphism in angiographically documented coronary artery disease.
    Almawi WY, Ameen G, Tamim H, Finan RR, Irani-Hakime N.
    J Thromb Thrombolysis; 2004 Jun; 17(3):199-205. PubMed ID: 15353918
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Retinal vein occlusion: a form of venous thrombosis or a complication of atherosclerosis? A meta-analysis of thrombophilic factors.
    Janssen MC, den Heijer M, Cruysberg JR, Wollersheim H, Bredie SJ.
    Thromb Haemost; 2005 Jun; 93(6):1021-6. PubMed ID: 15968383
    [Abstract] [Full Text] [Related]

  • 7. Thrombophilic mutations and risk of retinal vein occlusion.
    Biancardi AL, Gadelha T, Borges WI, Vieira de Moraes H, Spector N.
    Arq Bras Oftalmol; 2007 Jun; 70(6):971-4. PubMed ID: 18235909
    [Abstract] [Full Text] [Related]

  • 8. Prothrombin polymorphism A19911G, factor V HR2 haplotype A4070G, and plasminogen activator-inhibitor-1 polymorphism 4G/5G and the risk of retinal vein occlusion.
    Kuhli-Hattenbach C, Hellstern P, Nägler DK, Kohnen T, Hattenbach LO.
    Ophthalmic Genet; 2017 Jun; 38(5):413-417. PubMed ID: 28085526
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Thrombophilic and cardiovascular risk factors for retinal vein occlusion.
    Bucciarelli P, Passamonti SM, Gianniello F, Artoni A, Martinelli I.
    Eur J Intern Med; 2017 Oct; 44():44-48. PubMed ID: 28684050
    [Abstract] [Full Text] [Related]

  • 11. The platelet glycoprotein Ia/IIa gene polymorphism C807T/G873A: a novel risk factor for retinal vein occlusion.
    Dodson PM, Haynes J, Starczynski J, Farmer J, Shigdar S, Fegan G, Johnson RJ, Fegan C.
    Eye (Lond); 2003 Aug; 17(6):772-7. PubMed ID: 12928694
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Prediction of ischemic stroke in young Indians: is thrombophilia profiling a way out?
    Chatterjee T, Gupta N, Choudhry VP, Behari M, Saxena R, Ashraf MZ.
    Blood Coagul Fibrinolysis; 2013 Jun; 24(4):449-53. PubMed ID: 23337710
    [Abstract] [Full Text] [Related]

  • 14. Factor V G1691A, prothrombin G20210A and methylenetetrahydrofolate reductase polymorphism C677T are not associated with coronary artery disease and type 2 diabetes mellitus in western Iran.
    Rahimi Z, Nomani H, Mozafari H, Vaisi-Raygani A, Madani H, Malek-Khosravi S, Parsian A.
    Blood Coagul Fibrinolysis; 2009 Jun; 20(4):252-6. PubMed ID: 19349859
    [Abstract] [Full Text] [Related]

  • 15. Genetic determinants of fasting and post-methionine hyperhomocysteinemia in patients with retinal vein occlusion.
    Marcucci R, Giusti B, Betti I, Evangelisti L, Fedi S, Sodi A, Cappelli S, Menchini U, Abbate R, Prisco D.
    Thromb Res; 2003 Apr 15; 110(1):7-12. PubMed ID: 12877902
    [Abstract] [Full Text] [Related]

  • 16. Prevalence of factor V Leiden, prothrombin G20210A, and MTHFR C677T mutations in 200 healthy Jordanians.
    Eid SS, Rihani G.
    Clin Lab Sci; 2004 Apr 15; 17(4):200-2. PubMed ID: 15559724
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The association of factor V G1961A (factor V Leiden), prothrombin G20210A, MTHFR C677T and PAI-1 4G/5G polymorphisms with recurrent pregnancy loss in Bosnian women.
    Jusić A, Balić D, Avdić A, Pođanin M, Balić A.
    Med Glas (Zenica); 2018 Aug 01; 15(2):158-163. PubMed ID: 29703881
    [Abstract] [Full Text] [Related]

  • 19. [Thrombophilia - a risk factor of retinal vein occlusion?].
    Karska-Basta I, Kubicka-Trzaska A, Romanowska-Dixon B, Undas A.
    Klin Oczna; 2013 Aug 01; 115(1):29-33. PubMed ID: 23882736
    [Abstract] [Full Text] [Related]

  • 20. Clinical impact of factor V Leiden, prothrombin G20210A, and MTHFR C677T mutations among sickle cell disease patients of Central India.
    Nishank SS, Singh MP, Yadav R.
    Eur J Haematol; 2013 Nov 01; 91(5):462-6. PubMed ID: 23992124
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.